JP2012508575A5 - - Google Patents

Download PDF

Info

Publication number
JP2012508575A5
JP2012508575A5 JP2011536276A JP2011536276A JP2012508575A5 JP 2012508575 A5 JP2012508575 A5 JP 2012508575A5 JP 2011536276 A JP2011536276 A JP 2011536276A JP 2011536276 A JP2011536276 A JP 2011536276A JP 2012508575 A5 JP2012508575 A5 JP 2012508575A5
Authority
JP
Japan
Prior art keywords
cells
natural killer
cell population
pharmaceutical composition
foxp3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011536276A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012508575A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/PT2009/000060 external-priority patent/WO2010056144A2/en
Publication of JP2012508575A publication Critical patent/JP2012508575A/ja
Publication of JP2012508575A5 publication Critical patent/JP2012508575A5/ja
Pending legal-status Critical Current

Links

JP2011536276A 2008-11-13 2009-11-13 Foxp3+ナチュラルキラーT細胞および免疫関連疾患の治療方法 Pending JP2012508575A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11436208P 2008-11-13 2008-11-13
US61/114,362 2008-11-13
PT10476409 2009-09-25
PT104764 2009-09-25
PCT/PT2009/000060 WO2010056144A2 (en) 2008-11-13 2009-11-13 Foxp3+ natural kiler t-cells and the treatment of immune related diseases

Publications (2)

Publication Number Publication Date
JP2012508575A JP2012508575A (ja) 2012-04-12
JP2012508575A5 true JP2012508575A5 (cg-RX-API-DMAC7.html) 2013-01-17

Family

ID=42138978

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011536276A Pending JP2012508575A (ja) 2008-11-13 2009-11-13 Foxp3+ナチュラルキラーT細胞および免疫関連疾患の治療方法

Country Status (8)

Country Link
US (1) US20120114675A1 (cg-RX-API-DMAC7.html)
EP (1) EP2356222A2 (cg-RX-API-DMAC7.html)
JP (1) JP2012508575A (cg-RX-API-DMAC7.html)
CN (1) CN102216448A (cg-RX-API-DMAC7.html)
AU (1) AU2009314704A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0915255A2 (cg-RX-API-DMAC7.html)
CA (1) CA2743502A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010056144A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102603892B (zh) * 2012-02-22 2013-10-30 尉军 一种肿瘤标志物foxp3抗原多肽及应用
BR112016020919A2 (pt) * 2014-03-12 2018-01-23 Yeda Res & Dev redução dos níveis ou da atividade sistêmica de células t regulatórias para o tratamento de doença e lesão do snc
RU2739770C2 (ru) * 2014-06-11 2020-12-28 полибайосепт ГмбХ Экспансия лимфоцитов с использованием композиции цитокинов для активной клеточной иммунотерапии
TWI702290B (zh) * 2015-04-07 2020-08-21 富禾生醫股份有限公司 經修飾之自然殺手t細胞、醫藥組合物及其用途
CN105039255A (zh) * 2015-09-09 2015-11-11 广州赛莱拉干细胞科技股份有限公司 一种nkt细胞诱导培养的添加剂及诱导培养的方法
CN107475194B (zh) * 2017-10-09 2018-07-24 天津长和生物技术有限公司 Nkt细胞培养基、培养方法及二者的应用
US20220184172A1 (en) * 2019-04-19 2022-06-16 The Regents Of The University Of California Ampk/caspase-6 axis controls liver damage in nonalcoholic steatohepatitis
CA3158133A1 (en) 2020-04-28 2021-11-04 Lyell Immunopharma, Inc. Methods for culturing cells
WO2025221808A1 (en) * 2024-04-15 2025-10-23 Trustees Of Tufts College Efficient epigenetic reprogramming of t effector cells into stable regulatory t cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2082951C (en) 1991-03-15 1999-12-21 Robert M. Platz Pulmonary administration of granulocyte colony stimulating factor
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
ATE460475T1 (de) * 2000-04-11 2010-03-15 Univ Southern California Methode zur verhinderung der transplantatabstossung unter verwendung von tgf- beta zur induktion von t-suppressorzellen
EP1556071B1 (en) * 2002-10-25 2011-01-19 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Methods to prevent tumor recurrence by blockade of tgf-beta

Similar Documents

Publication Publication Date Title
JP2012508575A5 (cg-RX-API-DMAC7.html)
Pieren et al. The adaptive immune system in early life: The shift makes it count
Fina et al. Regulation of gut inflammation and th17 cell response by interleukin-21
Heiseke et al. CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell–mediated protection from colitis
Schnupf et al. Segmented filamentous bacteria, Th17 inducers and helpers in a hostile world
Sarra et al. Il-23/Il-17 Axis in IBD
Lang et al. How important is vitamin D in preventing infections?
Levings et al. T-regulatory 1 cells: a novel subset of CD4+ T cells with immunoregulatory properties
Wu et al. Microbiota-specific Th17 cells: Yin and Yang in regulation of inflammatory bowel disease
Secombes et al. Overview of the fish adaptive immune system
JP2012515213A5 (cg-RX-API-DMAC7.html)
CN102271702A (zh) 抗第三方中枢记忆性t细胞、产生其的方法及其在移植和疾病治疗中的用途
Aso et al. Adipose-derived mesenchymal stem cells restore impaired mucosal immune responses in aged mice
Ahlberg et al. Innate immune responses induced by the saponin adjuvant Matrix-M in specific pathogen free pigs
Madan et al. Cenicriviroc, a CCR2/CCR5 antagonist, promotes the generation of type 1 regulatory T cells
Schrum et al. Bacterial infection induces expression of functional MHC class II molecules in murine and human osteoblasts
JP2008534620A (ja) 制御性t細胞を用いた移植組織の拒絶反応の防止
Lozano‐Ojalvo et al. Oral immunotherapy with egg peptides induces innate and adaptive tolerogenic responses
Lin et al. The co-administrating of recombinant porcine IL-2 could enhance protective immune responses to PRV inactivated vaccine in pigs
ES2731849T3 (es) Composiciones para la inducción específica de antígeno de inmunotolerancia mediante inmunización oral
Zhao et al. Mesenteric CD103+ DCs initiate switched coxsackievirus B3 VP1-specific IgA response to intranasal chitosan-DNA vaccine through secreting BAFF/IL-6 and promoting Th17/Tfh differentiation
Sakthivel et al. CCL5 regulation of mucosal chlamydial immunity and infection
Shim et al. CD4+ CD25+ regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model
Rynda‐Apple et al. Active immunization using a single dose immunotherapeutic abates established EAE via IL‐10 and regulatory T cells
JP2020535832A5 (cg-RX-API-DMAC7.html)